Matteo Turetta
Overview
Explore the profile of Matteo Turetta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Grisard E, Coan M, Cesaratto L, Rigo I, Zandona L, Paulitti A, et al.
EBioMedicine
. 2019 Jul;
46:79-93.
PMID: 31303496
Background: Metastatic colorectal cancer (CRC) remains a deadly disease. Identifying locally advanced CRC patients with high risk of developing metastasis and improving outcome of metastatic CRC patients require discovering master...
12.
Soldati G, Del Ben F, Brisotto G, Biscontin E, Bulfoni M, Piruska A, et al.
Am J Transl Res
. 2019 Jan;
10(12):4004-4016.
PMID: 30662646
In a recent paper we presented an innovative method of liquid biopsy, for the detection of circulating tumor cells (CTC) in the peripheral blood. Using microfluidics, CTC are individually encapsulated...
13.
Turetta M, Bulfoni M, Brisotto G, Fasola G, Zanello A, Biscontin E, et al.
Cancers (Basel)
. 2018 Aug;
10(8).
PMID: 30110953
Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work,...
14.
Turetta M, Del Ben F, Brisotto G, Biscontin E, Bulfoni M, Cesselli D, et al.
Curr Med Chem
. 2018 Jun;
25(35):4616-4637.
PMID: 29874987
In the present review, we describe three hot topics in cancer research such as circulating tumor cells, exosomes, and 3D environment models. The first section is dedicated to microfluidic platforms...
15.
Bulfoni M, Turetta M, Del Ben F, Di Loreto C, Beltrami A, Cesselli D
Int J Mol Sci
. 2016 Oct;
17(10).
PMID: 27783057
Although the enumeration of circulating tumor cells (CTC) defined as expressing both epithelial cell adhesion molecule and cytokeratins (EpCAM⁺/CK⁺) can predict prognosis and response to therapy in metastatic breast, colon...
16.
Del Ben F, Turetta M, Celetti G, Piruska A, Bulfoni M, Cesselli D, et al.
Angew Chem Int Ed Engl
. 2016 Jun;
55(30):8581-4.
PMID: 27247024
The number of circulating tumor cells (CTCs) in blood is strongly correlated with the progress of metastatic cancer. Current methods to detect CTCs are based on immunostaining or discrimination of...
17.
Bulfoni M, Gerratana L, Del Ben F, Marzinotto S, Sorrentino M, Turetta M, et al.
Breast Cancer Res
. 2016 Mar;
18(1):30.
PMID: 26961140
Background: Although recent models suggest that the detection of Circulating Tumor Cells (CTC) in epithelial-to-mesenchymal transition (EM CTC) might be related to disease progression in metastatic breast cancer (MBC) patients,...
18.
Venturelli L, Nappini S, Bulfoni M, Gianfranceschi G, Dal Zilio S, Coceano G, et al.
Sci Rep
. 2016 Feb;
6:21629.
PMID: 26899926
The mesenchymal state in cancer is usually associated with poor prognosis due to the metastatic predisposition and the hyper-activated metabolism. Exploiting cell glucose metabolism we propose a new method to...